• Editas Medicine to Host Conference Call Discussing Fourth Quarter and Full Year 2020 Results and Corporate Update

    Source: Nasdaq GlobeNewswire / 18 Feb 2021 16:02:00   America/New_York

    CAMBRIDGE, Mass., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced that it will host a conference call and webcast on Thursday, February 25, 2021, at 8:00 a.m. ET to discuss a corporate update and results for the fourth quarter and full year of 2020.

    Conference Call & Webcast Details
    Date:Thursday, February 25, 2021 
    Time:8:00 am Eastern Time
    Toll Free:(844) 348-3801
    International:(213) 358-0955
    Conference ID:7172199
    Webcast:https://edge.media-server.com/mmc/p/hg6sbc5q

    A live webcast of the conference call can be accessed in the Investors section of Editas Medicine website at https://www.editasmedicine.com/.


    About Editas Medicine
    As a leading genome editing company, Editas Medicine is focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cas12a (also known as Cpf1) genome editing systems into a robust pipeline of treatments for people living with serious diseases around the world. Editas Medicine aims to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for a broad class of diseases. For the latest information and scientific presentations, please visit www.editasmedicine.com.

    Contacts:
    Media
    Cristi Barnett
    (617) 401-0113
    cristi.barnett@editasmed.com

    Investors
    Editas Medicine Investor Relations
    (617) 401-9052
    ir@editasmed.com


    Primary Logo

Share on,